or Try an Advanced Search...

    Lymphocytic Leukemia Stocks List

    Symbol Grade Name % Change
    LGND B Ligand Pharmaceuticals Incorporated 2.27
    EBS C Emergent Biosolutions, Inc. 0.85
    TEVA D Teva Pharmaceutical Industries 0.23
    CLLS F Cellectis S.A. 0.54
    EGRX F Eagle Pharmaceuticals, Inc. 18.75
    GMAB F Genmab A/S 0.88
    BIIB F Biogen Idec Inc. -0.07
    AFMD F Affimed Therapeutics B.V. -0.76
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
    Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Cancer Biotechnology Drugs Monoclonal Antibodies Monoclonal Antibody Multiple Myeloma Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Biopharmaceutical Blastoma CD19 Cd20

    Related ETFs - A few ETFs which own one or more of the above listed Lymphocytic Leukemia stocks.

    Symbol Grade Name Weight
    ISRA A Market Vectors Israel ETF 8.64
    MNTL D Tema Neuroscience and Mental Health ETF 7.54
    PJP C PowerShares Dynamic Pharmaceuticals 6.34
    BIS C ProShares UltraShort Nasdaq Biotechnology 6.31
    FBT C First Trust Amex Biotech Index Fund 5.99
    View all Lymphocytic Leukemia ETFs...
    Compare ETFs
    Compare ISRA to PJP Compare MNTL to BIS Compare MNTL to PJP

        Lymphocytic Leukemia Stocks Recent News

        Date Stock Title
        Nov 22 BIIB Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
        Nov 22 BIIB Biogen price target lowered to $207 from $251 at Mizuho
        Nov 21 GMAB Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 TEVA Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
        Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
        Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 AFMD Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
        Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
        Nov 19 TEVA Teva Pharmaceutical Industries Limited (TEVA) Jefferies London Healthcare Conference (Transcript)
        Nov 19 BIIB Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
        Nov 18 BIIB Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
        Nov 18 BIIB Needham downgrades Biogen on slow growth of Alzheimer's drug
        Nov 18 BIIB Biogen cut to hold by Needham on lack of catalysts, slow Leqembi sales
        Nov 18 BIIB Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™
        Nov 18 BIIB Is Biogen Inc. (BIIB) A Cheap NASDAQ Stock To Invest In Now?
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
        Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Cancer Biotechnology Drugs Monoclonal Antibodies Monoclonal Antibody Multiple Myeloma Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Biopharmaceutical Blastoma CD19 Cd20
        Lymphocytic Leukemia

        Lymphocytic leukemia is a type of cancer that affects the white blood cells, or lymphocytes, in the body. It is a type of leukemia, which is a cancer of the blood and bone marrow. In lymphocytic leukemia, the body produces too many abnormal lymphocytes, which can crowd out healthy white blood cells, red blood cells, and platelets. This can lead to anemia, infections, and other serious health problems. Treatment for lymphocytic leukemia typically involves chemotherapy, radiation, and/or stem cell transplant.

        Browse All Tags